Premium Access

Understanding the role of RIPK1 kinase activity in atherogenesis: a genetic versus pharmacological approach

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Congress Presentation

About the speaker

Ms Pauline Puylaert

University of Antwerp, Antwerp (Belgium)
0 follower

4 more presentations in this session

Targeting BACE1 to restore functional angiogenesis in type 2 diabetes

Speaker: Miss E. Clavane (Leeds, GB)


Smooth muscle cell-specific deletion of S100A4 reroutes smooth muscle cell fate and modifies the inflammatory status of murine atherosclerotic lesions

Speaker: Mr L. Cardoso dos Santos (Geneva, CH)


Focused ultrasound-induced targeted delivery of miR-155-5p inhibitor employing biomimetic microbubbles reduces NADPH oxidase expression and inflammation in atherosclerotic ApoE-/- mice

Speaker: Doctor A. Manea (Bucharest, RO)


Necroptosis, unlike pyroptosis mediates right ventricular damage in pulmonary arterial hypertension

Speaker: Miss I. Jarabicova (Bratislava, SK)


Access the full session

Moderated poster 12 - Vascular Diseases

Speakers: Ms P. Puylaert, Miss E. Clavane, Mr L. Cardoso dos Santos, Doctor A. Manea, Miss I. Jarabicova

About the event


Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb